STK25 and neoplasm: Here, it is demonstrated that STK25 global knockout (STK25<sup>-/-</sup>) mice and STK25-knockout tumor-bearing mice exhibited enhanced effectiveness of anti-PD-1 immunotherapy, which leads to significant tumor suppression with increased recruitment of CD8<sup>+</sup> T cells.